Form D · Biotechnology
Thoclor US, Inc.
Florham Park, NJ · CIK 0002109348
Offering snapshot reported Feb 12, 2026 · SEC filing
- Reported sold
- $225K Offering amount: $500K
- Investors reported
- 3 Form D · investor count
- Minimum accepted
- $50K Reported outside-investor minimum
- First sale
- Feb 4, 2026 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Feb 12, 2026 | Initial | $225,000 | No comparison | 3 | SEC filing |
Offering details
- Securities
- Other
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-573399
Simple Agreement for Future Equity (SAFE)
Source: Form D, filed Feb 12, 2026. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Tim Ayers | Director |
| Tom Hadley | Director, Executive |
| Mark Rattray | Director, Executive |
| Hennie Roos | Director |
| Stuart Russell | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
1 Shetland Road
Florham Park, NJ, 07932
Florham Park, NJ, 07932